ArticleOphthalmology and therapy2022

Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation.

Dhanashree Ratra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.